Sartar Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 6

Sartar Therapeutics General Information

Description

Developer of a soft tissue sarcoma therapy intended to treat the unmet medical needs of patients suffering from cancer. The company exploits principles of precision medicine, drug repurposing and reformulation, and the repositioning of anagrelide, enabling patients receiving cancer therapies to access novel therapeutic options.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • Terkko Health Hub
  • Haartmaninkatu 4, building 14
  • 00290 Helsinki
  • Finland
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Terkko Health Hub
  • Haartmaninkatu 4, building 14
  • 00290 Helsinki
  • Finland

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sartar Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sartar Therapeutics‘s full profile, request access.

Request a free trial

Sartar Therapeutics Patents

Sartar Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4680198-A1 A pharmaceutical composition for subcutaneous injection of anagrelide Pending 15-Mar-2023
WO-2024189275-A1 A pharmaceutical composition for subcutaneous injection of anagrelide Inactive 15-Mar-2023
JP-2026517082-A Pharmaceutical composition for subcutaneous injection of anagrelide Pending 15-Mar-2023
CA-3239568-A1 Synergistic compositions for use in the treatment of cancer Pending 07-Dec-2021
EP-4444314-A1 Synergistic compositions for use in the treatment of cancer Pending 07-Dec-2021 A61K31/501
To view Sartar Therapeutics’s complete patent history, request access »

Sartar Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sartar Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sartar Therapeutics‘s full profile, request access.

Request a free trial

Sartar Therapeutics FAQs

  • When was Sartar Therapeutics founded?

    Sartar Therapeutics was founded in 2016.

  • Where is Sartar Therapeutics headquartered?

    Sartar Therapeutics is headquartered in Helsinki, Finland.

  • What is the size of Sartar Therapeutics?

    Sartar Therapeutics has 5 total employees.

  • What industry is Sartar Therapeutics in?

    Sartar Therapeutics’s primary industry is Drug Discovery.

  • Is Sartar Therapeutics a private or public company?

    Sartar Therapeutics is a Private company.

  • What is Sartar Therapeutics’s current revenue?

    The current revenue for Sartar Therapeutics is .

  • How much funding has Sartar Therapeutics raised over time?

    Sartar Therapeutics has raised $2.7M.

  • Who are Sartar Therapeutics’s investors?

    Excedea Capital, Business Finland, Nordic Mentor Network For Entrepreneurship, SPARK Finland, and Health Incubator Helsinki have invested in Sartar Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process